Grant Funding received to date from the Australian Federal Government totals USD $3.25 millionNEW YORK, June 20, 2023 (GLOBE NEWSWIRE)…
FREMONT, CA, June 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company…
The Company Has Been Selected to Present at Singular’s Small / Micro Cap Stock Outperformance Conference San Antonio, Texas, June…
DELRAY BEACH, Fla., June 20, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc., a global digital health company delivering technology platforms, infrastructure,…
Sequantrix identifies and validates novel, antifibrotic targets by leveraging one of the world’s largest human single-cell, multi-modal datasets in the…
Has served in interim role since January 2023HOLLISTON, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO)…
Emergex and Brazil’s IBMP to co-fund Phase II and Phase III studies of Emergex’s Dengue Fever and Betacoronavirus T cell-priming…
The Company’s Nelivabon Program Pairs Novel Compound with Companion Diagnostics to Treat MDD patientsMUNICH, Germany, June 20, 2023 (GLOBE NEWSWIRE)…
- Using ProMagen™ in combination with standard chemicals or other biological solutions demonstrated more efficient disease control and boosted yields…
20 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Appeal of Delisting Determination Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage…